ClaireMorris, Author at Pharmaphorum

About ClaireMorris

Posts by ClaireMorris :

A new paradigm for drug discovery: part three – online shopping for scientists: new tools for finding and engaging service vendors

In part three of four, Dr Kevin Lustig and Dr Maria Thompson discuss how new tools for engaging service vendors can accelerate your drug discovery program. It will come as no surprise to anyone reading this that the pharmaceutical industry is currently suffering from quite a few problems…

A new paradigm for drug discovery: part three – online shopping for scientists: new tools for finding and engaging service vendors

https://pharmaphorum.com/views-and-analysis/a-new-paradigm-for-drug-discovery-part-three-online-shopping-for-scientists-new-tools-for-finding-and-engaging-service-vendors/

Patient perspectives: Penny Perez

Penny Perez highlights the rare disorder of Williams syndrome by sharing her son, Keith’s, story. Penny’s son has a rare disorder known as Williams syndrome. In this Williams syndrome awareness month Penny discusses…

Patient perspectives: Penny Perez

https://pharmaphorum.com/views-and-analysis/patient-perspectives-penny-perez-old/

Merck and Pfizer to collaborate on diabetes drug

Multimillion-dollar diabetes collaboration between two leading pharma players. A global collaboration has been formed on phase III-ready diabetes drug ertugliflozin between Pfizer and Merck.

Merck and Pfizer to collaborate on diabetes drug

https://pharmaphorum.com/news/merck-and-pfizer-to-collaborate-on-diabetes-drug/

Bayer to spend $1.1 billion for contraceptive device

German pharma giant to make a large acquisition payment for device maker. Bayer will gain access to the contraceptive device Essure by acquiring its maker Conceptus for a purchase price of around $1.1 billion.

Bayer to spend $1.1 billion for contraceptive device

https://pharmaphorum.com/news/bayer_to_spend_1-1_billion_for_contraceptive_device_/

European Medicines Agency told not to disclose data

General Court of the European Union stops access to documents submitted to the European regulator. Following cases brought by AbbVie and InterMune, the European Medicines Agency has been told not to publish what the companies say is commercially sensitive data.

European Medicines Agency told not to disclose data

https://pharmaphorum.com/news/european_medicines_agency_told_not_to_disclose_data_/

Physician online communities – sponsor or build? (part 2)

Kay Wesley concludes her thoughts on whether pharma should sponsor or build physician online communities by exploring the pros and cons of both. In part one of this article, I considered the growth of online physician communities and the different types of community available –third party…

Physician online communities – sponsor or build? (part 2)

https://pharmaphorum.com/views-and-analysis/physician_online_communities_-_sponsor_or_build_part_2/

Market Access for nebulisers in asthma – UK payer insights

As our market access themed month commences, Dr Joanna Entwistle and Julia Glover explore market access barriers to nebulisers for asthma in the UK. Asthma is an inflammatory disease of the airways characterised by chronic inflammation associated with airway hyper-responsiveness…

Market Access for nebulisers in asthma – UK payer insights

https://pharmaphorum.com/views-and-analysis/market-access-for-nebulisers-in-asthma-uk-payer-insights/

Editor’s voice: April – digital and social media

Did you miss any of our digital and social media articles this month? An overview of highlights of this content is shared here. The discipline focus of our content throughout April has been on digital and social media. This article highlights some of my personal…

Editor’s voice: April – digital and social media

https://pharmaphorum.com/views-and-analysis/editors_voice_april_-_digital_and_social_media/

US eases emergency contraception restrictions

US regulator eases the availability of emergency contraception and relaxes its age restriction. Teva’s Plan B One-Step (levonorgestrel) ‘morning after’ pill is to become available over-the-counter in the US, removing the need to see a pharmacist, and it will be open to any woman or girl 15 years of age or older.

US eases emergency contraception restrictions

https://pharmaphorum.com/news/us_eases_emergency_contraception_restrictions/

1 2 3 4 5 >»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Search

Advanced Search

Trending

About ClaireMorris

Posts by ClaireMorris :